首页> 外文期刊>Behavioural pharmacology >Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats.
【24h】

Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats.

机译:NMDA受体通道阻滞剂MK-801和美金刚对Wistar-Kyoto和自发性高血压大鼠运动能力和延迟奖励的耐受性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

N-Methyl-D-aspartate (NMDA) receptor blockade enhances motor activity and stimulates dopamine metabolism, effects shared with classical psychostimulant drugs. The present study aimed to characterize behavioral effects of two NMDA receptor channel blockers, MK-801 and memantine, in both Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats. In Experiment 1, SHR rats demonstrated higher spontaneous locomotor activity and spent more time in the central area of the open field apparatus compared with WKY rats. Rats of both strains pre-treated with MK-801 (0.01-0.3 mg/kg) or memantine (1-32 mg/kg) demonstrated dose-dependent increases in the total distance traveled and time spent in the central area. Experiment 2 was based on the two-lever discrete-trial delayed reinforcement task in which rats could press one lever to obtain one pellet immediately or another lever for four pellets delivered after a variable delay (0-60 s). Tolerance to delay of reward did not differ between strains. MK-801 (0.03-0.3 mg/kg) and memantine (1-10 mg/kg) produced small, but significant, facilitation of the large-reward lever responding and markedly impaired operant performance at higher dose levels (increased number of missed trials). For both experiments, effects of MK-801 and memantine were more pronounced in WKY compared with SHR rats. Additional studies are needed to address the utility of noncompetitive NMDA receptor blockers in the treatment of attention deficit and hyperactivity disorder.
机译:N-甲基-D-天门冬氨酸(NMDA)受体阻滞剂可增强运动活动并刺激多巴胺代谢,这是经典精神刺激药物共有的作用。本研究旨在表征两种NMDA受体通道阻滞剂MK-801和美金刚在Wistar-Kyoto(WKY)和自发性高血压(SHR)大鼠中的行为作用。在实验1中,与WKY大鼠相比,SHR大鼠表现出更高的自发运动能力,并且在野外器械的中央区域花费了更多时间。用MK-801(0.01-0.3 mg / kg)或美金刚(1-32 mg / kg)预处理的两种品系的大鼠均显示出其在中部地区的总旅行距离和所花费的时间呈剂量依赖性。实验2基于两杆离散试验延迟补强任务,在该任务中,大鼠可以按一个杠杆立即获得一个药丸,或者按可变延迟(0-60 s)后递送四个药丸的另一个杠杆。不同品系对奖励延迟的耐受性没有差异。 MK-801(0.03-0.3 mg / kg)和美金刚(1-10 mg / kg)产生了小但显着的大剂量杠杆响应促进作用,并且在较高剂量水平时显着损害了操作性能(增加了漏诊的次数) )。对于这两个实验,与SHR大鼠相比,WKY中MK-801和美金刚的作用更为明显。需要更多的研究来解决非竞争性NMDA受体阻滞剂在治疗注意力缺陷和多动障碍中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号